This website contains promotional content and is intended for Healthcare Professionals based in the United Kingdom only. Some content is only relevant to HCPs practising in Great Britain (England, Scotland, Wales). This website is optimised for desktop use, and some features may perform differently on mobile devices.

Adverse event reporting can be found at the bottom of the page.

Listen to the Hot Topics in Atopic Dermatitis podcasts

Your hosts, Emmanuel Toni and Aisling Clery, are Advanced Nurse Practitioners in Medical Dermatology, working in large NHS Foundation Trusts in London. Both are passionate about education and co-host their own podcast called ‘Dermatology UK The Podcast’, where they chat about all things skin.

Join Emmanuel and Aisling in this podcast series Hot Topics in Atopic Dermatitis, in which they discuss some of the current trends impacting the treatment landscape of patients with atopic dermatitis with UK dermatology specialists.

1. Long-term disease control — when to escalate or change treatment

2. Moving from systemics to advanced therapy (when to make that switch?)

3. Novel Therapies — tips on how to quickly access treatment for patients

4. Skin of Colour — accuracy in assessment and diagnosis

Long term disease control  when to escalate or change treatment

Listen to Emmanuel and Aisling talking to Dr Rick Woolf, Clinical Lead for Medical Dermatology at the St John’s Institute of Dermatology, Guy’s and St Thomas’ NHS Foundation Trust and member of the British Association of Dermatologists National Guideline Committee on the use of biologics.

In this episode of Hot Topics in Atopic Dermatitis, they chat about long-term disease control, the role of safety in treatment decisions, patient outcome measures, and factors that influence treatment change.

Moving from systemics to advanced therapy  when to make that switch

Listen to Emmanuel and Aisling talking to Dr Andrew Pink, a leading Consultant Dermatologist and the Director of the Adult Clinical Trials Unit at the St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, London.

In this episode of Hot Topics in Atopic Dermatitis, they chat about long-term disease control, impact on service provision, access to novel therapies, and patient outcome measures.

Novel therapies — tips on how to access treatment for young patients

Listen to Emmanuel and Aisling talking to Dr Tess McPherson, Lead Paediatric and Adolescent Dermatologist at Oxford University Hospitals NHS Foundation Trust, President of the British Society of Paediatric and Adolescent Dermatology, and author of ‘Young People’s Skin Conditions’.

In this episode of Hot Topics in Atopic Dermatitis they chat about factors that influence treatment choice, the role of novel therapies in the treatment landscape, and accessibility for paediatric patients.

Skin of colour — accuracy of process in assessment and diagnosis

Listen to Emmanuel and Aisling talking to Dr Marisa Taylor, Consultant Dermatologist and Biologics Lead at Epsom and St. Helier University Hospitals NHS Trust and Co-founder and Consultant Lead for The Skin of Colour Training UK.

In this episode of Hot Topics in Atopic Dermatitis they chat about treatment choice and factors that influence these decisions, patient outcome measures in different skin types, and treatment monitoring requirements.

Discover other resources
 

Photo of the paper ADCT test

Atopic Dermatitis Control Test (ADCT)

Atopic dermatitis, a type of eczema, may be affecting your patient’s life in more ways than you know.

The ADCT gives a measure of how controlled your patient’s eczema is. Use these 6 concise questions to evaluate all dimensions of atopic dermatitis control.

Development of ADCT involved literature review as well as interviews with patients and physicians, and was funded by Sanofi and Regeneron.

Try the ADCT

MAT-XU-2401605 (v1.0) Date of preparation: May 2024